← Leaderboards
Rachael Wolters
Vanderbilt University
$368,550
Attributed
$368,550
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $122.8K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$368,550 · 1
By mechanism
K01$368,550 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Mark R Denison$28,746,770
- Helen Keipp Talbot$7,247,906
- William A Grissom$10,339,134
- Richard M Caprioli$30,630,395
- Kevin Whittle Graepel$113,263
Others in their field
Other Rising Stars on “Clinical Trials”
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Suma Babu · Massachusetts General Hospital$36,168,406
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
Research focus
Clinical TrialsAnimal ModelAerosolizedAnimalsAntibodiesAntibody TherapyAnimal Model DevelopmentAirway EpitheliumBindingBiologicalBiological ModelsBiological ProductsBiophysical PropertiesBiophysicsBronchopneumoniaCareerCareer DevelopmentCell Culture TechniquesCell ImmortalizationCell LineCellsCessation Of LifeChildhoodComplex
Grant awards (3)
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies$122,850
K01 · FY2025 · OD · contact PI
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies$122,850
K01 · FY2024 · OD · contact PI
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies$122,850
K01 · FY2023 · OD · contact PI